BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35960733)

  • 1. A high-quality severe combined immunodeficiency (SCID) rat bioresource.
    Miyasaka Y; Wang J; Hattori K; Yamauchi Y; Hoshi M; Yoshimi K; Ishida S; Mashimo T
    PLoS One; 2022; 17(8):e0272950. PubMed ID: 35960733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in
    Boettcher AN; Li Y; Ahrens AP; Kiupel M; Byrne KA; Loving CL; Cino-Ozuna AG; Wiarda JE; Adur M; Schultz B; Swanson JJ; Snella EM; Ho CS; Charley SE; Kiefer ZE; Cunnick JE; Putz EJ; Dell'Anna G; Jens J; Sathe S; Goldman F; Westin ER; Dekkers JCM; Ross JW; Tuggle CK
    Front Immunol; 2020; 11():100. PubMed ID: 32117254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg
    Wei X; Lai Y; Li B; Qin L; Xu Y; Lin S; Wang S; Wu Q; Liang Q; Huang G; Deng Q; Liu P; Wu D; Lai L; Yao Y; Li P
    Sci Rep; 2017 Aug; 7(1):7720. PubMed ID: 28798321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated
    Zhao Y; Liu P; Xin Z; Shi C; Bai Y; Sun X; Zhao Y; Wang X; Liu L; Zhao X; Chen Z; Zhang H
    Front Genet; 2019; 10():401. PubMed ID: 31134127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial and
    Song J; Wang G; Hoenerhoff MJ; Ruan J; Yang D; Zhang J; Yang J; Lester PA; Sigler R; Bradley M; Eckley S; Cornelius K; Chen K; Kolls JK; Peng L; Ma L; Chen YE; Sun F; Xu J
    Front Immunol; 2018; 9():429. PubMed ID: 29593714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
    Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
    Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs.
    Kang JT; Cho B; Ryu J; Ray C; Lee EJ; Yun YJ; Ahn S; Lee J; Ji DY; Jue N; Clark-Deener S; Lee K; Park KW
    Reprod Biol Endocrinol; 2016 Nov; 14(1):74. PubMed ID: 27809915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.
    Alzubi J; Pallant C; Mussolino C; Howe SJ; Thrasher AJ; Cathomen T
    Sci Rep; 2017 Sep; 7(1):12475. PubMed ID: 28963568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of severe combined immunodeficiency rats.
    Mashimo T; Takizawa A; Kobayashi J; Kunihiro Y; Yoshimi K; Ishida S; Tanabe K; Yanagi A; Tachibana A; Hirose J; Yomoda J; Morimoto S; Kuramoto T; Voigt B; Watanabe T; Hiai H; Tateno C; Komatsu K; Serikawa T
    Cell Rep; 2012 Sep; 2(3):685-94. PubMed ID: 22981234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of RAG2 knockout pigs as animal model for severe combined immunodeficiency.
    Suzuki S; Iwamoto M; Hashimoto M; Suzuki M; Nakai M; Fuchimoto D; Sembon S; Eguchi-Ogawa T; Uenishi H; Onishi A
    Vet Immunol Immunopathol; 2016 Oct; 178():37-49. PubMed ID: 27496741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.
    Mou W; He J; Chen X; Zhang H; Ren X; Wu X; Ni X; Xu B; Gui J
    Immunogenetics; 2017 Jan; 69(1):29-38. PubMed ID: 27566612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.
    Ali N; Flutter B; Sanchez Rodriguez R; Sharif-Paghaleh E; Barber LD; Lombardi G; Nestle FO
    PLoS One; 2012; 7(8):e44219. PubMed ID: 22937164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.
    Mazurier F; Fontanellas A; Salesse S; Taine L; Landriau S; Moreau-Gaudry F; Reiffers J; Peault B; Di Santo JP; de Verneuil H
    J Interferon Cytokine Res; 1999 May; 19(5):533-41. PubMed ID: 10386866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Il2rg gene-targeted severe combined immunodeficiency pigs.
    Suzuki S; Iwamoto M; Saito Y; Fuchimoto D; Sembon S; Suzuki M; Mikawa S; Hashimoto M; Aoki Y; Najima Y; Takagi S; Suzuki N; Suzuki E; Kubo M; Mimuro J; Kashiwakura Y; Madoiwa S; Sakata Y; Perry ACF; Ishikawa F; Onishi A
    Cell Stem Cell; 2012 Jun; 10(6):753-758. PubMed ID: 22704516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency.
    Lei S; Ryu J; Wen K; Twitchell E; Bui T; Ramesh A; Weiss M; Li G; Samuel H; Clark-Deener S; Jiang X; Lee K; Yuan L
    Sci Rep; 2016 Apr; 6():25222. PubMed ID: 27118081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
    Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
    Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9.
    Hashikawa Y; Hayashi R; Tajima M; Okubo T; Azuma S; Kuwamura M; Takai N; Osada Y; Kunihiro Y; Mashimo T; Nishida K
    Sci Rep; 2020 Jun; 10(1):9957. PubMed ID: 32561775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational landscape of severe combined immunodeficiency patients from Turkey.
    Firtina S; Yin Ng Y; Hatirnaz Ng O; Kiykim A; Aydiner E; Nepesov S; Camcioglu Y; Sayar EH; Reisli I; Torun SH; Cogurlu T; Uygun D; Simsek IE; Kaya A; Cipe F; Cagdas D; Yucel E; Cekic S; Uygun V; Baris S; Ozen A; Ozbek U; Sayitoglu M
    Int J Immunogenet; 2020 Dec; 47(6):529-538. PubMed ID: 32445296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.